Trial
NCT00003858
Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
National Cancer Institute (NCI)
Condition
Prostate Cancer
Intervention
mitoxantrone hydrochloride
Why stopped
The study was not activated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-13